Curetech Skincare came into existence in the year 2006 form the esteemed vision foresight of Mr Ashwani Singla.
More than just a Third Party manufacturer of Topical Products, at Curetech Skincare, we work with our development team as an extension of formulation development for our valuable customers. In doing so, we leverage our core strength, our team’s technical leadership in topical development. Our unparalleled expertise ranges from Concept to Commercialization for any semi-solid product.
We are experts at risk-based approaches, strategic planning and innovative drug product design, and implementation of GMP principles. We can help you identify “Go/No Go” decisions earlier and help your company avoid unnecessary costs and delays.
Using years of manufacturing & formulation developmental experience, combined with understanding the best path forward for regulatory affairs, we are the single destination to reach topical product manufacturing goals ir-respective whether it’s a pharmaceutical dosage form or in cosmetics..
Capacity & Regulatory status
Curetech Skincare and Metrocraft are group companies of Curetech Skincare. Both the units are WHO cGMP accredited for semi solid dosage forms and have dedicated sections for steroidal preparations
having a large list of clientele including MNCs and Large Pharmaceutical Companies.
Installed capacity in both of the units is:
 Curetech Skincare : 16.80 million tubes a year ( in additional 1.2 million in Cosmetics)
 Metrocraft : 7 million tubes a year
We are renowned for providing the best products for the enrichment and wellness of the skin.
Focus on Topicals
The primary focus of Curetech Skincare is semi-solid formulation development, formulation, analysis, testing, cGMP & manufacturing.
Novel Formulations in Cosmetics:
We develop novel formulations providing clients with a competitive edge.

Curetech Skincare came into existence in the year 2006 form the esteemed vision foresight of Mr Ashwani Singla.
More than just a Third Party manufacturer of Topical Products, at Curetech Skincare, we work with our development team as an extension of formulation development for our valuable customers. In doing so, we leverage our core strength, our team’s technical leadership in topical development. Our unparalleled expertise ranges from Concept to Commercialization for any semi-solid product.
We are experts at risk-based approaches, strategic planning and innovative drug product design, and implementation of GMP principles. We can help you identify “Go/No Go” decisions earlier and help your company avoid unnecessary costs and delays.
Using years of manufacturing & formulation developmental experience, combined with understanding the best path forward for regulatory affairs, we are the single destination to reach topical product manufacturing goals ir-respective whether it’s a pharmaceutical dosage form or in cosmetics..
Capacity & Regulatory status
Curetech Skincare and Metrocraft are group companies of Curetech Skincare. Both the units are WHO cGMP accredited for semi solid dosage forms and have dedicated sections for steroidal preparations
having a large list of clientele including MNCs and Large Pharmaceutical Companies.
Installed capacity in both of the units is:
 Curetech Skincare : 16.80 million tubes a year ( in additional 1.2 million in Cosmetics)
 Metrocraft : 7 million tubes a year
We are renowned for providing the best products for the enrichment and wellness of the skin.
Focus on Topicals
The primary focus of Curetech Skincare is semi-solid formulation development, formulation, analysis, testing, cGMP & manufacturing.
Novel Formulations in Cosmetics:
We develop novel formulations providing clients with a competitive edge.